KANSAS CITY, Mo., March 01, 2017 -- H&R Block, Inc. (NYSE:HRB) today announced that its Board of Directors declared a quarterly cash dividend of 22 cents per share, payable April 3, 2017, to shareholders of record as of March 14, 2017.
H&R Block has paid quarterly dividends consecutively since the company went public in 1962.
About H&R Block
H&R Block, Inc. (NYSE:HRB) is a global consumer tax services provider. Tax return preparation services are provided by professional tax preparers in approximately 12,000 company-owned and franchise retail tax offices worldwide, and through H&R Block tax software products for the DIY consumer. H&R Block also offers adjacent Tax Plus products and services. In fiscal 2016, H&R Block had annual revenues of over $3 billion with 23.2 million tax returns prepared worldwide. For more information, visit the H&R Block Newsroom.
For Further Information Investor Relations: Colby Brown, (816) 854-4559, [email protected] Media Relations: Gene King, (816) 854-4672, [email protected]


Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 



